Mensing Doesn't Nix Generic-Fosamax Claims, 3rd Circ. Told
A federal judge wrongfully used the U.S. Supreme Court's Pliva Inc. v. Mensing ruling to preempt design defect claims against generic-drug makers in multidistrict litigation over the safety of Merck &...To view the full article, register now.
Already a subscriber? Click here to view full article